Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Bausch & Lomb Inc. (NYSE:BOL)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
July 24Price hit new 52-week low ($32.95)
Upcoming Events
Oct  1Dividend payment of $0.26
Location
One Bausch & Lomb Place
Rochester, NY 14604
Phone: (716) 338-6000
Fax: (716) 338-6007
Email: apanzarella@bausch.com
Employees (last reported count): 12,400
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 500
Ownership
·Insider and 5%+ Owners: 64%
·Institutional: 95% (267% of float)
(587 institutions)
·Net Inst. Buying: 4.71M shares (+8.46%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Bausch & Lomb Incorporated is engaged in the development, manufacture and marketing of healthcare products for the eye. The Company has three business segments, vision care, pharmaceuticals and surgical. The vision care segment includes contact lenses, lens care products and vision accessories. The pharmaceuticals segment includes generic and proprietary prescription ophthalmic drugs and over-the-counter products, with an emphasis on ophthalmic medications. The surgical segment includes cataract, refractive and other ophthalmic surgery products and equipment. In April 2001, the Company announced the creation of a new company, Technovision, focused on the research and development of new refractive surgical technologies for vision correction and enhancement.
More from Market Guide: Expanded Business Description

Financial Summary
Bausch and Lomb Inc. develops, manufactures and markets healthcare products for the eye in three business segments: vision care, pharmaceuticals, and surgical. For the six months ended 6/30/01, revenues fell 4% to $826.2 million. Net income before acct. change fell 93% to $5.5 million. Revenues reflect a decrease in lens care, pharmaceutical and refractive sales. Earnings reflect the inclusion of a $16.9 million restructuring charge.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

William Waltrip, 63
Chairman
--  --  
Stephen McCluski, 48
CFO, Sr. VP
$673K$66K
Robert Stiles, 51
Sr. VP and Gen. Counsel
--  --  
Gary Aron, 58
Sr. VP - Research, Devel., and Engineering
324K--  
Dwain Hahs, 48
Sr. VP, Global Supply Chain Management
645K--  
Dollar amounts are as of 30-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:BOLAs of 31-Aug-2001
Price and Volume
52-Week Low
on 24-July-2001
$32.95 
Recent Price$36.37 
52-Week High
on 1-Mar-2001
$54.93 
Beta0.30 
Daily Volume (3-month avg)418.2K
Daily Volume (10-day avg)272.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-0.4%
52-Week Change
relative to S&P500
+33.7%
Share-Related Items
Market Capitalization$1.95B
Shares Outstanding53.6M
Float19.1M
Dividends & Splits
Annual Dividend (indicated)$1.04 
Dividend Yield2.86%
Last Split: 2 for 1 on 1-July-1991
Per-Share Data
Book Value (mrq)$18.94 
Earnings (ttm)$0.25 
Earnings (mrq)$0.13 
Sales (ttm)$32.32 
Cash (mrq)$15.21 
Valuation Ratios
Price/Book (mrq)1.92 
Price/Earnings (ttm)143.75 
Price/Sales (ttm)1.12 
Income Statements
Sales (ttm)$1.73B
EBITDA (ttm)$221.5M
Income available to common (ttm)$13.7M
Profitability
Profit Margin (ttm)1.7%
Operating Margin (ttm)3.8%
Fiscal Year
Fiscal Year EndsDec 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)0.93%
Return on Equity (ttm)1.33%
Financial Strength
Current Ratio (mrq)2.18 
Debt/Equity (mrq)0.91 
Total Cash (mrq)$815.4M
Short Interest
As of 8-Aug-2001
Shares Short2.88M
Percent of Float15.1%
Shares Short
(Prior Month)
3.86M
Short Ratio6.77 
Daily Volume425.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.